History of Benzodiazepine Prescriptions and Risk of Dementia: Possible Bias Due to Prevalent Users and Covariate Measurement Timing in a Nested Case-Control Study

Kathryn Richardson (Corresponding Author), Katharina Mattishent, Yoon Kong Loke, Nicholas Steel, Chris Fox, Carlota M. Grossi, Kathleen Bennett, Ian Maidment, Malaz Boustani, Fiona E. Matthews, Phyo K. Myint, Noll L. Campbell, Carol Brayne, Louise Robinson, George Savva

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)
5 Downloads (Pure)

Abstract

Previous estimates of whether long-term exposure to benzodiazepines increases dementia risk are conflicting and are compromised by the difficulty of controlling for confounders and by reverse causation. We investigated how estimates for the association between benzodiazepine use and later dementia incidence varied based on study design choices using a case-control study nested within the United Kingdom's Clinical Practice Research Datalink. N=40,770 dementia cases diagnosed between April 2006 and July 2015 were matched to 283,933 controls on age, sex, available data history and deprivation. Benzodiazepines and Z-drug prescriptions were ascertained in a drug exposure period 4-20 years prior to dementia diagnosis. Estimates varied with the inclusion of new or prevalent users, with the timing of covariate ascertainment, and with varying time between exposure and outcome. There was no association between any new prescription of benzodiazepines and dementia (adjusted odds ratio 1.03; 95% confidence interval 1.00, 1.07), while among prevalent users and inverse association was observed (adjusted odds ratio 0.91; 95% confidence interval 0.87, 0.95), although this was likely induced by unintentional adjustment for colliders. By considering the choice of confounders and timing of exposure and covariate measurement, overall our findings are consistent with no causal effect of benzodiazepines or Z-drugs on dementia incidence.
Original languageEnglish
Pages (from-to)1228–1236
Number of pages9
JournalAmerican Journal of Epidemiology
Volume188
Issue number7
Early online date27 Mar 2019
DOIs
Publication statusPublished - Jul 2019
EventAnnual meeting of the British Pharmacological Society 2016 - London, United Kingdom
Duration: 13 Dec 201615 Dec 2016

Keywords

  • benzodiazepines
  • bias (epidemiology)
  • case-control studies
  • dementia
  • risk
  • DEVELOPING ALZHEIMERS-DISEASE
  • MEDICATION
  • MORTALITY
  • ASSOCIATION

Fingerprint Dive into the research topics of 'History of Benzodiazepine Prescriptions and Risk of Dementia: Possible Bias Due to Prevalent Users and Covariate Measurement Timing in a Nested Case-Control Study'. Together they form a unique fingerprint.

Cite this